BMS have published a series of Pyrrolopyridine−Pyridone Based Met kinase inhibitors
Filed under: Uncategorized | Tagged: BMS, kinase, Met, Preclinical, Research | Comments Off
Merrimack initiate phase I trial of ErbB3 MAb MM-121
Posted on August 11, 2008 by crimsoncanary
Merrimack Pharmaceuticals have initiated a phase I clinical study of ErbB3 MAb MM-121 for the treatment of cancer
Filed under: Uncategorized | Tagged: phase I, Monoclonal, ErbB3, MM-121, MM121, Merrimack | Comments Off
